Investor Update

Results for the 9 months ended 31 March 2022

© 2022 Cogstate Ltd. All rights reserved.

Disclaimer

This presentation has been prepared by Cogstate Limited ('Cogstate'). The information in this presentation is of a general nature and does not purport to be complete, nor does it contain all the information which would be required in a prospectus prepared in accordance with the requirements of the Corporations Act. This presentation may contain statements, opinions, projections, forecasts and other material (forward looking statements), based on various assumptions. Those assumptions may or may not prove to be correct. None of Cogstate, its respective officers, employees, agents, advisers or any other person named in this presentation makes any representation as to the accuracy or likelihood of fulfilment of any forward looking statements or any of the assumptions upon which they are based.

The information contained in this presentation does not take into account the investment objectives, financial situation or particular needs of any recipient and is not financial product advice. Before making an investment decision, recipients of this presentation should consider their own needs and situation and, if necessary, seek independent, professional advice.

To the extent permitted by law, Cogstate and its respective officers, employees, agents and advisers give no warranty, representation or guarantee as to the accuracy, completeness or reliability of the information contained in this presentation. Further, none of Cogstate and its respective officers, employees, agents and advisers accept, to the extent permitted by law, responsibility for any loss, claim, damages, costs or expenses arising out of, or in connection with, the information contained in this presentation. Any recipient of this presentation should independently satisfy themselves as to the accuracy of all information contained herein.

We are on a mission to democratize brain health assessment across clinical research and clinical care... combining proven science with disruptive digital innovation to make the measurement of cognition as simple, standardized, actionable and common as the measurement of blood pressure.

Company Snapshot

Cogstate is a leading neuroscience technology company optimising brain health assessments to advance the development of new medicines and to enable earlier insights in healthcare.

After more than 20 years spent developing and scientifically validating our technologies, Cogstate is a leading provider of digital brain health assessments:

  • • Selected to support world's top 10 pharma*

  • • More than 2,000 academic and clinical research trials

  • • More than 2 million tests administered

Cogstate tests are highly automated, easy to use, sensitive to change and accepted by global regulators.

Cogstate is growing rapidly. For the calendar year ended 31 December 2021, Cogstate recorded revenue of US$42m and EBIT of US$10m.

*Ranked by revenue, as at Dec 2021

Cogstate was founded in Melbourne, Australia, where approx. 25% of our workforce is based. We have a small presence in the UK, but most of our staff are based in the USA.

Our largest customer base is pharma / biotech companies developing new drugs or other treatments. Global clinical trials is a $40B+ industry that seeks tools for better go/no-go decisions that can speed new therapies to market.

In the next decade, better solutions for screening, diagnosing, and treating brain disorders will be imperative. Cogstate is a leader and uniquely positioned to support this need for clinical evaluation and self-assessment at scale.

Market Dynamics

World's population aged 60+ will double to 2.1 billion by 20501.

Biotech investors predict 2020s to be decade of neurology renaissance akin to 2010 for oncology2

85% of CNS drugs fail in trials and digital endpoints address many data quality issues that contribute3

Modern AD drug candidates focus on prevention, so early detection of cognitive decline is central4

1. https://bit.ly/369Ta6N, 2.https://bit.ly/3LzLA5M , 3.https://bit.ly/3rQEvpF, 4.https://bit.ly/3uOxdV5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

CogState Ltd. published this content on 20 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2022 23:54:01 UTC.